Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction

Toxins (Basel). 2020 Jun 14;12(6):394. doi: 10.3390/toxins12060394.

Abstract

Botulinum toxin A (BoNT-A) is a potent protein that can selectively modulate neurotransmission from nerve endings, resulting in the blocking of neurotransmitter releases and causing muscular paralysis [...].

Keywords: botulinum toxin; chronic pelvic pain syndrome; functional urological disorders; inflammation; interstitial cystitis; neurogenic detrusor overactivity; overactive bladder; pain.

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Acetylcholine Release Inhibitors / adverse effects
  • Acetylcholine Release Inhibitors / therapeutic use*
  • Animals
  • Botulinum Toxins, Type A / adverse effects
  • Botulinum Toxins, Type A / therapeutic use*
  • Humans
  • Lower Urinary Tract Symptoms / drug therapy*
  • Lower Urinary Tract Symptoms / physiopathology
  • Recovery of Function
  • Treatment Outcome
  • Urinary Tract / innervation*
  • Urologic Diseases / drug therapy*
  • Urologic Diseases / physiopathology

Substances

  • Acetylcholine Release Inhibitors
  • Botulinum Toxins, Type A